nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—systemic lupus erythematosus—systemic scleroderma	0.777	1	CtDrD
Dapsone—CYP2C8—Mometasone—systemic scleroderma	0.0489	0.355	CbGbCtD
Dapsone—CYP2C9—Leflunomide—systemic scleroderma	0.022	0.159	CbGbCtD
Dapsone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0203	0.147	CbGbCtD
Dapsone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0195	0.141	CbGbCtD
Dapsone—CYP2C19—Prednisone—systemic scleroderma	0.0131	0.0947	CbGbCtD
Dapsone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0079	0.0573	CbGbCtD
Dapsone—CYP2C9—cardial valve—systemic scleroderma	0.00663	0.237	CbGeAlD
Dapsone—CYP3A4—Prednisone—systemic scleroderma	0.00632	0.0458	CbGbCtD
Dapsone—Pulmonary eosinophilia—Captopril—systemic scleroderma	0.00469	0.0847	CcSEcCtD
Dapsone—Pulmonary eosinophilia—Lisinopril—systemic scleroderma	0.00332	0.06	CcSEcCtD
Dapsone—PTGS2—skeletal joint—systemic scleroderma	0.00207	0.074	CbGeAlD
Dapsone—MPO—artery—systemic scleroderma	0.00191	0.0683	CbGeAlD
Dapsone—Nephrotic syndrome—Captopril—systemic scleroderma	0.00177	0.032	CcSEcCtD
Dapsone—Nerve injury—Prednisone—systemic scleroderma	0.00165	0.0298	CcSEcCtD
Dapsone—MPO—endothelium—systemic scleroderma	0.00162	0.0577	CbGeAlD
Dapsone—MPO—blood vessel—systemic scleroderma	0.00149	0.0532	CbGeAlD
Dapsone—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00104	0.624	CbGdCrCtD
Dapsone—Proteinuria—Captopril—systemic scleroderma	0.000974	0.0176	CcSEcCtD
Dapsone—Protein urine present—Captopril—systemic scleroderma	0.000961	0.0174	CcSEcCtD
Dapsone—Albuminuria—Leflunomide—systemic scleroderma	0.000945	0.0171	CcSEcCtD
Dapsone—PTGS1—artery—systemic scleroderma	0.000908	0.0324	CbGeAlD
Dapsone—Albuminuria—Mycophenolic acid—systemic scleroderma	0.000902	0.0163	CcSEcCtD
Dapsone—CYP2C18—digestive system—systemic scleroderma	0.000871	0.0311	CbGeAlD
Dapsone—PTGS2—artery—systemic scleroderma	0.000868	0.031	CbGeAlD
Dapsone—PTGS1—endothelium—systemic scleroderma	0.000767	0.0274	CbGeAlD
Dapsone—MPO—connective tissue—systemic scleroderma	0.000765	0.0273	CbGeAlD
Dapsone—PTGS2—endothelium—systemic scleroderma	0.000733	0.0262	CbGeAlD
Dapsone—Albuminuria—Mycophenolate mofetil—systemic scleroderma	0.000712	0.0129	CcSEcCtD
Dapsone—PTGS1—blood vessel—systemic scleroderma	0.000708	0.0252	CbGeAlD
Dapsone—FMO3—lung—systemic scleroderma	0.0007	0.025	CbGeAlD
Dapsone—MPO—skin of body—systemic scleroderma	0.00069	0.0246	CbGeAlD
Dapsone—Proteinuria—Lisinopril—systemic scleroderma	0.00069	0.0125	CcSEcCtD
Dapsone—Protein urine present—Lisinopril—systemic scleroderma	0.000681	0.0123	CcSEcCtD
Dapsone—PTGS2—blood vessel—systemic scleroderma	0.000676	0.0241	CbGeAlD
Dapsone—Nasopharyngitis—Mometasone—systemic scleroderma	0.000633	0.0114	CcSEcCtD
Dapsone—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00063	0.376	CbGdCrCtD
Dapsone—Influenza—Mometasone—systemic scleroderma	0.000612	0.011	CcSEcCtD
Dapsone—MPO—digestive system—systemic scleroderma	0.000552	0.0197	CbGeAlD
Dapsone—Muscular weakness—Captopril—systemic scleroderma	0.000548	0.0099	CcSEcCtD
Dapsone—Pancreatitis—Captopril—systemic scleroderma	0.000527	0.00951	CcSEcCtD
Dapsone—Sinusitis—Mometasone—systemic scleroderma	0.000512	0.00924	CcSEcCtD
Dapsone—Erythema—Pentoxifylline—systemic scleroderma	0.000494	0.00892	CcSEcCtD
Dapsone—Photosensitivity reaction—Captopril—systemic scleroderma	0.00049	0.00885	CcSEcCtD
Dapsone—Pharyngitis—Mometasone—systemic scleroderma	0.000486	0.00877	CcSEcCtD
Dapsone—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.000477	0.00862	CcSEcCtD
Dapsone—Vision blurred—Pentoxifylline—systemic scleroderma	0.000465	0.00841	CcSEcCtD
Dapsone—MPO—lung—systemic scleroderma	0.000461	0.0165	CbGeAlD
Dapsone—Pancreatitis—Azathioprine—systemic scleroderma	0.00046	0.0083	CcSEcCtD
Dapsone—Influenza—Leflunomide—systemic scleroderma	0.000443	0.008	CcSEcCtD
Dapsone—Nasopharyngitis—Mycophenolic acid—systemic scleroderma	0.000437	0.00789	CcSEcCtD
Dapsone—Pancreatitis—Leflunomide—systemic scleroderma	0.000434	0.00784	CcSEcCtD
Dapsone—Muscular weakness—Mycophenolic acid—systemic scleroderma	0.000431	0.00778	CcSEcCtD
Dapsone—Pharyngitis—Captopril—systemic scleroderma	0.000427	0.00771	CcSEcCtD
Dapsone—Influenza—Mycophenolic acid—systemic scleroderma	0.000422	0.00763	CcSEcCtD
Dapsone—Pancreatitis—Mycophenolic acid—systemic scleroderma	0.000414	0.00748	CcSEcCtD
Dapsone—Nasopharyngitis—Lisinopril—systemic scleroderma	0.000394	0.00711	CcSEcCtD
Dapsone—Tachycardia—Pentoxifylline—systemic scleroderma	0.000393	0.0071	CcSEcCtD
Dapsone—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.000387	0.00699	CcSEcCtD
Dapsone—Influenza—Lisinopril—systemic scleroderma	0.00038	0.00687	CcSEcCtD
Dapsone—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.000377	0.0068	CcSEcCtD
Dapsone—Pancreatitis—Lisinopril—systemic scleroderma	0.000373	0.00674	CcSEcCtD
Dapsone—Cough—Mometasone—systemic scleroderma	0.000372	0.00672	CcSEcCtD
Dapsone—Sinusitis—Leflunomide—systemic scleroderma	0.00037	0.00669	CcSEcCtD
Dapsone—CYP2C19—digestive system—systemic scleroderma	0.00037	0.0132	CbGeAlD
Dapsone—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.000369	0.00667	CcSEcCtD
Dapsone—Insomnia—Pentoxifylline—systemic scleroderma	0.000365	0.00658	CcSEcCtD
Dapsone—PTGS1—connective tissue—systemic scleroderma	0.000363	0.0129	CbGeAlD
Dapsone—Sinusitis—Mycophenolic acid—systemic scleroderma	0.000353	0.00638	CcSEcCtD
Dapsone—Vision blurred—Captopril—systemic scleroderma	0.000353	0.00637	CcSEcCtD
Dapsone—Pharyngitis—Leflunomide—systemic scleroderma	0.000352	0.00635	CcSEcCtD
Dapsone—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.000347	0.00627	CcSEcCtD
Dapsone—PTGS2—connective tissue—systemic scleroderma	0.000347	0.0124	CbGeAlD
Dapsone—Skin exfoliation—Prednisone—systemic scleroderma	0.000344	0.00621	CcSEcCtD
Dapsone—Proteinuria—Methotrexate—systemic scleroderma	0.000343	0.00619	CcSEcCtD
Dapsone—Muscular weakness—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00614	CcSEcCtD
Dapsone—Protein urine present—Methotrexate—systemic scleroderma	0.000338	0.0061	CcSEcCtD
Dapsone—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.000336	0.00606	CcSEcCtD
Dapsone—Influenza—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00602	CcSEcCtD
Dapsone—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.000332	0.006	CcSEcCtD
Dapsone—PTGS1—smooth muscle tissue—systemic scleroderma	0.000332	0.0118	CbGeAlD
Dapsone—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00033	0.00595	CcSEcCtD
Dapsone—PTGS1—skin of body—systemic scleroderma	0.000328	0.0117	CbGeAlD
Dapsone—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.000327	0.0059	CcSEcCtD
Dapsone—Cough—Captopril—systemic scleroderma	0.000327	0.0059	CcSEcCtD
Dapsone—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000319	0.00575	CcSEcCtD
Dapsone—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000319	0.00575	CcSEcCtD
Dapsone—Sinusitis—Lisinopril—systemic scleroderma	0.000318	0.00575	CcSEcCtD
Dapsone—PTGS2—smooth muscle tissue—systemic scleroderma	0.000317	0.0113	CbGeAlD
Dapsone—Tinnitus—Mycophenolic acid—systemic scleroderma	0.000315	0.00569	CcSEcCtD
Dapsone—PTGS2—skin of body—systemic scleroderma	0.000313	0.0112	CbGeAlD
Dapsone—Pharyngitis—Lisinopril—systemic scleroderma	0.000302	0.00546	CcSEcCtD
Dapsone—Tachycardia—Captopril—systemic scleroderma	0.000298	0.00538	CcSEcCtD
Dapsone—CYP3A5—digestive system—systemic scleroderma	0.000292	0.0104	CbGeAlD
Dapsone—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00526	CcSEcCtD
Dapsone—Vision blurred—Leflunomide—systemic scleroderma	0.000291	0.00525	CcSEcCtD
Dapsone—Skin exfoliation—Methotrexate—systemic scleroderma	0.000287	0.00519	CcSEcCtD
Dapsone—CYP2C9—digestive system—systemic scleroderma	0.000287	0.0102	CbGeAlD
Dapsone—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000284	0.00514	CcSEcCtD
Dapsone—Tinnitus—Lisinopril—systemic scleroderma	0.000284	0.00513	CcSEcCtD
Dapsone—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.000279	0.00504	CcSEcCtD
Dapsone—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000277	0.00501	CcSEcCtD
Dapsone—Vertigo—Leflunomide—systemic scleroderma	0.000277	0.00501	CcSEcCtD
Dapsone—Insomnia—Captopril—systemic scleroderma	0.000276	0.00499	CcSEcCtD
Dapsone—Abdominal pain—Mometasone—systemic scleroderma	0.000275	0.00497	CcSEcCtD
Dapsone—Body temperature increased—Mometasone—systemic scleroderma	0.000275	0.00497	CcSEcCtD
Dapsone—CYP2E1—digestive system—systemic scleroderma	0.000272	0.00971	CbGeAlD
Dapsone—Cough—Leflunomide—systemic scleroderma	0.000269	0.00486	CcSEcCtD
Dapsone—Erythema—Lisinopril—systemic scleroderma	0.000265	0.00479	CcSEcCtD
Dapsone—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00478	CcSEcCtD
Dapsone—Vertigo—Mycophenolic acid—systemic scleroderma	0.000264	0.00477	CcSEcCtD
Dapsone—PTGS1—digestive system—systemic scleroderma	0.000262	0.00935	CbGeAlD
Dapsone—CYP2E1—tendon—systemic scleroderma	0.000259	0.00924	CbGeAlD
Dapsone—Cough—Mycophenolic acid—systemic scleroderma	0.000257	0.00464	CcSEcCtD
Dapsone—Vomiting—Pentoxifylline—systemic scleroderma	0.000256	0.00463	CcSEcCtD
Dapsone—Psychotic disorder—Prednisone—systemic scleroderma	0.000255	0.00461	CcSEcCtD
Dapsone—Headache—Pentoxifylline—systemic scleroderma	0.000253	0.00456	CcSEcCtD
Dapsone—PTGS2—digestive system—systemic scleroderma	0.00025	0.00894	CbGeAlD
Dapsone—Vision blurred—Lisinopril—systemic scleroderma	0.00025	0.00451	CcSEcCtD
Dapsone—Gastrointestinal pain—Captopril—systemic scleroderma	0.00025	0.00451	CcSEcCtD
Dapsone—PTGS1—tendon—systemic scleroderma	0.000249	0.0089	CbGeAlD
Dapsone—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00449	CcSEcCtD
Dapsone—Tachycardia—Leflunomide—systemic scleroderma	0.000246	0.00444	CcSEcCtD
Dapsone—CYP3A5—lung—systemic scleroderma	0.000244	0.00869	CbGeAlD
Dapsone—Abdominal pain—Captopril—systemic scleroderma	0.000241	0.00436	CcSEcCtD
Dapsone—Body temperature increased—Captopril—systemic scleroderma	0.000241	0.00436	CcSEcCtD
Dapsone—Nausea—Pentoxifylline—systemic scleroderma	0.000239	0.00432	CcSEcCtD
Dapsone—PTGS2—tendon—systemic scleroderma	0.000238	0.0085	CbGeAlD
Dapsone—Vertigo—Lisinopril—systemic scleroderma	0.000238	0.0043	CcSEcCtD
Dapsone—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000234	0.00423	CcSEcCtD
Dapsone—Cough—Lisinopril—systemic scleroderma	0.000231	0.00418	CcSEcCtD
Dapsone—Muscular weakness—Prednisone—systemic scleroderma	0.000231	0.00416	CcSEcCtD
Dapsone—Insomnia—Leflunomide—systemic scleroderma	0.000228	0.00411	CcSEcCtD
Dapsone—CYP2E1—lung—systemic scleroderma	0.000227	0.00811	CbGeAlD
Dapsone—Pancreatitis—Prednisone—systemic scleroderma	0.000222	0.004	CcSEcCtD
Dapsone—Vomiting—Mometasone—systemic scleroderma	0.000221	0.00399	CcSEcCtD
Dapsone—CYP3A4—digestive system—systemic scleroderma	0.000219	0.00781	CbGeAlD
Dapsone—PTGS1—lung—systemic scleroderma	0.000219	0.00781	CbGeAlD
Dapsone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000218	0.00394	CcSEcCtD
Dapsone—Headache—Mometasone—systemic scleroderma	0.000218	0.00393	CcSEcCtD
Dapsone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000217	0.00392	CcSEcCtD
Dapsone—Tachycardia—Lisinopril—systemic scleroderma	0.000211	0.00381	CcSEcCtD
Dapsone—Body temperature increased—Azathioprine—systemic scleroderma	0.000211	0.00381	CcSEcCtD
Dapsone—Abdominal pain—Azathioprine—systemic scleroderma	0.000211	0.00381	CcSEcCtD
Dapsone—PTGS2—lung—systemic scleroderma	0.000209	0.00746	CbGeAlD
Dapsone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00377	CcSEcCtD
Dapsone—Nausea—Mometasone—systemic scleroderma	0.000207	0.00373	CcSEcCtD
Dapsone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000206	0.00372	CcSEcCtD
Dapsone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000203	0.00366	CcSEcCtD
Dapsone—Abdominal pain—Leflunomide—systemic scleroderma	0.000199	0.00359	CcSEcCtD
Dapsone—Body temperature increased—Leflunomide—systemic scleroderma	0.000199	0.00359	CcSEcCtD
Dapsone—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000197	0.00357	CcSEcCtD
Dapsone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000196	0.00355	CcSEcCtD
Dapsone—Insomnia—Lisinopril—systemic scleroderma	0.000196	0.00353	CcSEcCtD
Dapsone—Vomiting—Captopril—systemic scleroderma	0.000194	0.00351	CcSEcCtD
Dapsone—Headache—Captopril—systemic scleroderma	0.000191	0.00346	CcSEcCtD
Dapsone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00019	0.00343	CcSEcCtD
Dapsone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00019	0.00343	CcSEcCtD
Dapsone—Pancreatitis—Methotrexate—systemic scleroderma	0.000185	0.00334	CcSEcCtD
Dapsone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00334	CcSEcCtD
Dapsone—Nausea—Captopril—systemic scleroderma	0.000181	0.00328	CcSEcCtD
Dapsone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000177	0.00319	CcSEcCtD
Dapsone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000172	0.00311	CcSEcCtD
Dapsone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000171	0.0031	CcSEcCtD
Dapsone—Abdominal pain—Lisinopril—systemic scleroderma	0.000171	0.00309	CcSEcCtD
Dapsone—Body temperature increased—Lisinopril—systemic scleroderma	0.000171	0.00309	CcSEcCtD
Dapsone—Vomiting—Azathioprine—systemic scleroderma	0.000169	0.00306	CcSEcCtD
Dapsone—Headache—Azathioprine—systemic scleroderma	0.000167	0.00302	CcSEcCtD
Dapsone—Vomiting—Leflunomide—systemic scleroderma	0.00016	0.00289	CcSEcCtD
Dapsone—Nausea—Azathioprine—systemic scleroderma	0.000158	0.00286	CcSEcCtD
Dapsone—Headache—Leflunomide—systemic scleroderma	0.000158	0.00285	CcSEcCtD
Dapsone—Erythema—Prednisone—systemic scleroderma	0.000157	0.00284	CcSEcCtD
Dapsone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000155	0.0028	CcSEcCtD
Dapsone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000153	0.00276	CcSEcCtD
Dapsone—Headache—Mycophenolic acid—systemic scleroderma	0.00015	0.00272	CcSEcCtD
Dapsone—Pharyngitis—Methotrexate—systemic scleroderma	0.00015	0.00271	CcSEcCtD
Dapsone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00015	0.00271	CcSEcCtD
Dapsone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00015	0.00271	CcSEcCtD
Dapsone—Nausea—Leflunomide—systemic scleroderma	0.00015	0.0027	CcSEcCtD
Dapsone—Vision blurred—Prednisone—systemic scleroderma	0.000148	0.00268	CcSEcCtD
Dapsone—Nausea—Mycophenolic acid—systemic scleroderma	0.000143	0.00258	CcSEcCtD
Dapsone—Vertigo—Prednisone—systemic scleroderma	0.000141	0.00255	CcSEcCtD
Dapsone—Tinnitus—Methotrexate—systemic scleroderma	0.000141	0.00254	CcSEcCtD
Dapsone—Vomiting—Lisinopril—systemic scleroderma	0.000138	0.00248	CcSEcCtD
Dapsone—Headache—Lisinopril—systemic scleroderma	0.000136	0.00245	CcSEcCtD
Dapsone—Erythema—Methotrexate—systemic scleroderma	0.000132	0.00238	CcSEcCtD
Dapsone—Nausea—Lisinopril—systemic scleroderma	0.000128	0.00232	CcSEcCtD
Dapsone—Tachycardia—Prednisone—systemic scleroderma	0.000125	0.00226	CcSEcCtD
Dapsone—Vision blurred—Methotrexate—systemic scleroderma	0.000124	0.00224	CcSEcCtD
Dapsone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00218	CcSEcCtD
Dapsone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000119	0.00214	CcSEcCtD
Dapsone—Vertigo—Methotrexate—systemic scleroderma	0.000118	0.00213	CcSEcCtD
Dapsone—Insomnia—Prednisone—systemic scleroderma	0.000116	0.0021	CcSEcCtD
Dapsone—Cough—Methotrexate—systemic scleroderma	0.000115	0.00207	CcSEcCtD
Dapsone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000113	0.00203	CcSEcCtD
Dapsone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000105	0.0019	CcSEcCtD
Dapsone—Abdominal pain—Prednisone—systemic scleroderma	0.000102	0.00183	CcSEcCtD
Dapsone—Body temperature increased—Prednisone—systemic scleroderma	0.000102	0.00183	CcSEcCtD
Dapsone—Insomnia—Methotrexate—systemic scleroderma	9.71e-05	0.00175	CcSEcCtD
Dapsone—Gastrointestinal pain—Methotrexate—systemic scleroderma	8.78e-05	0.00159	CcSEcCtD
Dapsone—Body temperature increased—Methotrexate—systemic scleroderma	8.49e-05	0.00153	CcSEcCtD
Dapsone—Abdominal pain—Methotrexate—systemic scleroderma	8.49e-05	0.00153	CcSEcCtD
Dapsone—Vomiting—Prednisone—systemic scleroderma	8.17e-05	0.00148	CcSEcCtD
Dapsone—Headache—Prednisone—systemic scleroderma	8.05e-05	0.00145	CcSEcCtD
Dapsone—Nausea—Prednisone—systemic scleroderma	7.63e-05	0.00138	CcSEcCtD
Dapsone—Vomiting—Methotrexate—systemic scleroderma	6.83e-05	0.00123	CcSEcCtD
Dapsone—Headache—Methotrexate—systemic scleroderma	6.73e-05	0.00121	CcSEcCtD
Dapsone—Nausea—Methotrexate—systemic scleroderma	6.38e-05	0.00115	CcSEcCtD
